Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: Insights from the BIONICS study

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Legr, Matthieu ^a,b,c   Berardinis, Benedetta De ^d   Gaggin, Hanna K ^e   Magrini, Laura ^d   Belcher, Arianna ^e   Zancla, Benedetta ^d   Femia, Alexra ^c   Simon, My ^e   Motiwala, Shweta ^e   Sambhare, Rasika ^f   Somma, Salvatore Di ^d   Mebazaa, Alexre ^a,b,c   Vaidya, Vishal S ^f   Januzzi, James L ^e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c AP HP Saint Louis and Lariboisière University Hospitals   (France)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; FUROSEMIDE; KIDNEY INJURY MOLECULE 1; LOOP DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; THIAZIDE DIURETIC AGENT; ACETYLGLUCOSAMINIDASE; ACUTE PHASE PROTEIN; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

ACUTE HEART FAILURE; AGED; ARTICLE; BLOOD SAMPLING; CARDIORENAL SYNDROME; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EMERGENCY WARD; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAROXYSMAL DYSPNEA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RECEIVER OPERATING CHARACTERISTIC; THORAX PAIN; URINALYSIS; ACUTE KIDNEY FAILURE; BLOOD; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; URINE; VERY ELDERLY;

ACETYLGLUCOSAMINIDASE; ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; BIOMARKERS; CARDIO-RENAL SYNDROME; CYSTATIN C; FEMALE; FIBRINOGEN; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIPOCALIN-2; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 84911414050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112313     Document Type: Article

References (25)

1. Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, et al. (2007) Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13: 599-608.
2. Van Kimmenade RRJ, Januzzi JL Jr (2012) Emerging biomarkers in heart failure. Clin Chem 58: 127-138.
3. Ronco C, Cicoira M, McCullough PA (2012) Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 60: 1031-1042.
4. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, et al. (2011) The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 57: 1752-1761.
5. Jungbauer CG, Birner C, Jung B, Buchner S, Lubnow M, et al. (2011) Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome. Eur J Heart Fail 13: 1104-1110.
6. Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, et al. (2010) Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart Br Card Soc 96: 1297-1302.
7. Alvelos M, Pimentel R, Pinho E, Gomes A, Lourenc?o P, et al. (2011) Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. Clin J Am Soc Nephrol 6: 476-481.
8. Macdonald S, Arendts G, Nagree Y, Xu X-F (2012) Neutrophil Gelatinase- Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study. BMC Cardiovasc Disord 12: 8.
9. Maisel AS, Mueller C, Fitzgerald R, Xu XF (2011) Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail 13: 846-851.
10. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, et al. (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364: 797-805.
11. Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, et al. (2012) Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367: 2296-2304.
12. Legrand M, Payen D (2013) Case scenario: Hemodynamic management of postoperative acute kidney injury. Anesthesiology 118: 1446-1454.
13. Legrand M, Januzzi JL Jr, Mebazaa A (2013) Critical research on biomarkers: what's new? Intensive Care Med 39: 1861-1863.
14. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54: 1012-24.
15. Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH (2010) Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 16: 49-54.
16. Breidthardt T, Socrates T, Drexler B, Noveanu M, Heinisch C, et al. (2012) Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care 16: R2.
17. Shrestha K, Shao Z, Singh D, Dupont M, Tang WH (2012) Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure. Am J Cardiol 110: 1329-1335.
18. Lassus JP, Nieminen MS, Peuhkurinen K, Pulkki K, Siirila? -Waris K, et al. (2010) Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J 31: 2791-2798.
19. Zamora E, Lupón J, de Antonio M, Vila J, Gala?n A, et al. (2012) Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification. PloS One 7: e51234.
20. Damman K, Ng Kam Chuen MJ, MacFadyen RJ, Lip GY, Gaze D, et al. (2011) Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J Am Coll Cardiol 57: 2233-2241.
21. Park M, Vittinghoff E, Liu KD, Shlipak MG, Hsu CY (2013) Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation. Biomark Insights 8: 15-18.
22. Royakkers AA, Korevaar JC, van Suijlen JD, Hofstra LS, Kuiper MA, et al. (2011) Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med 37: 493-501.
23. Hoffmann D, Bijol V, Krishnamoorthy A, Gonzalez VR, Frendl G, et al. (2012) Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury. Am J Pathol 181: 818-828.
24. Ahmad T, Fiuzat M, Pencina MJ, Geller NL, Zannad F, et al. (2014) Charting a Roadmap for Heart Failure Biomarker Studies. JACC Heart Fail S: 2213-1779.
25. Legrand M, Mebazaa A, Ronco C, Januzzi JL Jr. (2014) When cardiac failure, kidney dysfunction, and kidney injury intersect in acute conditions: the case of cardiorenal syndrome. Crit Care Med 42: 2109-17.